NCT01577849View on ClinicalTrials.gov

Safety and Pharmacokinetic Characteristics of DP-R206(Vitamin D3) in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Healthy

Interventions

DRUG

Vitamin D3

administration of Vitamin D3 24,000 IU

DRUG

DP-R206

administration of DP-R206 (150mg ibandronate / 24,000IU Vitamin D3)

Trial Locations (1)

Unknown

Chonbuk national University Hospital, Jeonju

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alvogen Korea

INDUSTRY

NCT01577849 - Safety and Pharmacokinetic Characteristics of DP-R206(Vitamin D3) in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter